Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.093 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |